Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.5%

4 terminated/withdrawn out of 89 trials

Success Rate

95.3%

+8.8% vs industry average

Late-Stage Pipeline

45%

40 trials in Phase 3/4

Results Transparency

35%

28 of 81 completed trials have results

Key Signals

2 recruiting28 with results

Enrollment Performance

Analytics

Phase 4

36(76.6%)

Phase 1

6(12.8%)

Phase 3

4(8.5%)

N/A

1(2.1%)

47Total

Phase 4(36)

Phase 1(6)

Phase 3(4)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (89)

Showing 20 of 89 trials

NCT07053345Phase 4Recruiting

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Role: lead

NCT07520747Recruiting

A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea

Role: lead

NCT04852692Terminated

A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Role: lead

NCT04214691Phase 1Completed

A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Role: lead

NCT03942120Completed

Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

Role: lead

NCT02229344Completed

Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

Role: lead

NCT01819818Completed

A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients

Role: lead

NCT04230252Phase 1Completed

A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Role: lead

NCT02505568Phase 3Completed

A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease

Role: lead

NCT01802359Terminated

A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction

Role: lead

NCT01741831Completed

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Role: lead

NCT01741844Completed

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence

Role: lead

NCT01182337Phase 1Completed

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Role: collaborator

NCT01310387Phase 3Completed

Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)

Role: collaborator

NCT01029132Not ApplicableCompleted

Characteristics of Treatment Responders to Galantamine

Role: collaborator

NCT01157585Phase 4Completed

Efficacy and Safety of Paliperidone ER in First Episode Psychosis

Role: collaborator

NCT02474563Completed

Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

Role: lead

NCT01624649Completed

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

Role: lead

NCT01400633Completed

An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome

Role: lead

NCT01819805Completed

A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen

Role: lead